{"cluster": 62, "subcluster": 22, "abstract_summ": "These attributes can be exploited to repurpose available viral protease inhibitors against SARS-CoV-2 M(Pro).To identify starting points for such therapeutics, we performed a large-scale screen of electrophile and non-covalent fragments through a combined mass spectrometry and X-ray approach against the SARS-CoV-2 main protease, one of two cysteine viral proteases essential for viral replication.The Mac1 domain of the multifunctional SARS-CoV-2 non-structural protein 3 (nsp3) is a potential COVID-19 drug target because it is suspected to enhance the ability of the virus to evade the human immune system.There are several efforts going on in the drug discovery to control the SARS-CoV-2 viral infection.Currently, there is no effective antiviral treatment for coronavirus disease 2019 (COVID-19); therefore, research efforts are focused on the rapid development of vaccines and antiviral drugs.", "title_summ": "Discovery of Drug-like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main proteaseVirtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperaturesFragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main proteaseDiscovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main proteaseSubstrate specificity profiling of SARS-CoV-2 main protease enables design of activity-based probes for patient-sample imaging", "title_abstract_phrases": "These attributes can be exploited to repurpose available viral protease inhibitors against SARS-CoV-2 M(Pro).Discovery of Drug-like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3The Mac1 domain of the multifunctional SARS-CoV-2 non-structural protein 3 (nsp3) is a potential COVID-19 drug target because it is suspected to enhance the ability of the virus to evade the human immune system.To identify starting points for such therapeutics, we performed a large-scale screen of electrophile and non-covalent fragments through a combined mass spectrometry and X-ray approach against the SARS-CoV-2 main protease, one of two cysteine viral proteases essential for viral replication.Currently, there is no effective antiviral treatment for coronavirus disease 2019 (COVID-19); therefore, research efforts are focused on the rapid development of vaccines and antiviral drugs.The SARS-CoV-2 main protease constitutes one of the most attractive antiviral drug targets."}